Endoscope Reprocessing Market

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 - 2027)

Report Code: MD 5654 May, 2022, by marketsandmarkets.com

[267 Pages Report] The endoscope reprocessing market is projected to reach USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027. The growth of this market is driven owing to iIncreasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during the forecast period.

Endoscope Reprocessing Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid -19 Impact On The Endoscope Reprocessing Market

Gastrointestinal endoscopy is a high-risk procedure for COVID-19 transmission. In an endoscopy, COVID-19 can be transmitted in several ways—from person to person through direct contact or respiratory droplets; generation of infected aerosols during endoscopy; and contact with contaminated endoscopic equipment, accessories, and body fluids. Endoscopic procedures, including gastroscopy, colonoscopy, and endoscopic retrograde cholangiopancreatography are performed every day, wherein endoscopists work on the GI lumen from a close distance, thereby getting exposed to many respiratory, oropharyngeal, and gastrointestinal infections.

The COVID-19 epidemic wreaked havoc on endoscopy centers globally. In March 2020, the multicenter survey from Northern Italy discovered that the COVID-19 positive patients were almost universally exposed in endoscopy units: 97.6% saw a decline in endoscopic activity, and 50% completed endoscopic treatments on the COVID-19 positive patients.

Medical staff is also at high risk of acquiring the COVID-19 infection due to the endoscopy unit. Endoscopes are relatively small and closed units with several people, including endoscopists, nursing staff, technicians, anesthetists, hospital attendants, patients waiting for multiple procedures, and a large number of small & big equipment providers. Patients with a high viral load in the respiratory secretions can contaminate the endoscopy air, as well as fomites with viruses that can remain viable for a longer duration, putting uninfected patients and endoscopy staff at risk.

Market Dynamics

Driver: Increasing requirement for endoscopy to diagnose and treat target diseases

Endoscopy procedures are minimally invasive surgeries done through one or more small incisions, using small tubes, tiny cameras, and surgical instruments. Less pain, a shorter or no hospital stay, and less complications related to pre- and post-surgery care are the major advantages of endoscopy procedures. Hence, these procedures are more cost-efficient, more effective, and safer than traditional open surgeries. Also, these procedures are covered by health insurance providers in rich countries such as the US, Canada, the UK, Germany, Australia, and a few countries in the Middle East, such as the UAE. These factors lead to a high preference for endoscopy procedures among patients and physicians. Every year, nearly 11.0 million colonoscopies, 6.1 million upper endoscopies, 313,000 flexible sigmoidoscopies, 178,400 upper endoscopic ultrasound examinations, and 169,500 endoscopic retrograde cholangiopancreatography procedures are performed in the US (Source: Gastroenterology 2019).

Endoscopy is increasingly being used for the diagnosis/treatment of several major disorders, such as cancer, orthopedic disorders, neurological disorders, and gastroesophageal reflux disorder (GERD). According to GLOBOCAN 2021, 457 960 new cancer cases were diagnosed in the UK in 2020, and this number is anticipated to reach 27.5 million by 2040 (an increase of 61.7%). As a result, there will be significant growth in the number of cancer surgeries; for instance, around 80% of cancer cases are likely to require surgery (Source: Lancet Commission on Global Surgery). Thus, the rising incidence of target diseases, including cancer, neurodegenerative, infectious, immune, metabolic, and cardiovascular diseases, is expected to accelerate the need for endoscopy procedures, which, in turn, would propel the endoscopy equipment market growth in the coming years

Increasing preference for minimally invasive surgeries

Compared to open surgery, in a minimally invasive surgery (MIS), such as endoscopy, patients can experience lower rates of complications, shorter hospital stays, decreased blood loss, and lower readmittance rates at a reduced cost. Minimally invasive implants, robotic-assisted surgeries, and virtual care can empower healthcare transformation.

The use of different visual and standard instruments, such as laparoscopic and endoscopic instruments, and high-powered magnification devices, has allowed physicians to decrease the morbidity of many surgical procedures by eliminating the need for a large surgical incision. Minimally invasive surgeries have evolved through the development of surgical microscopes equipped with a camera to get visual images for maxillofacial surgeries alongside endodontic and periodontal surgical procedures.

The volume of endoscopic minimally invasive surgeries has witnessed steady growth over the past decade. These surgeries include bariatric surgery, surgery for gastroesophageal reflux disease (GERD), hernia surgery, and solid organ surgery. According to the American Society for Metabolic and Bariatric Surgery, the number of bariatric surgeries increased from 158,000 in 2011 to 256,000 in 2019. With this growth in the number of endoscopic surgeries performed, the demand for automated endoscope reprocessors, which facilitate high-level disinfection of endoscopes, is set to rise.

Restraints: High overhead costs of endoscopy procedures with limited reimbursement in developing countries

The cost per colonoscopy, including purchase, maintenance, and reprocessing, ranges from USD 188.64 at high-volume centers (3,000 annual procedures) to USD 501.16 at low-volume centers (1,000 annual procedures). Accordingly, per procedure cost ranges from USD 87.48 to USD 262.45; repair cost ranges from USD 68.77 to USD 206.32; cleaning supplies and labor cost from USD 32.39 to USD 50.11, and the cost of infections requiring hospitalization ranges from USD 20.12 to USD 46.52. As disposable colonoscopes have entered the market, low-volume centers are most likely to achieve cost savings. Healthcare providers—particularly in developing countries such as India, Brazil, and Mexico—have low financial resources to invest in such costly and sophisticated technologies. Moreover, the staff should be trained for the efficient handling and maintenance of endoscopy systems and equipment. Maintaining endoscopy equipment is of vital importance as improperly reprocessed endoscopes can lead to cross-contamination and potentially expose patients to infections. This can incur additional costs. Moreover, the constant heating and cooling during disinfection procedures can cause wear and tear on the insertion and light guide tubes, which can hamper the durability of endoscopy equipment. All these factors add to the cost of endoscopy procedures.

Owing to the high capital, training, and maintenance costs, endoscopy procedures are generally expensive. For instance, the average cost of a colonoscopy procedure ranges from USD 2,000 to 3,000 in many developing countries. Also, in most Asian countries, there is limited or no reimbursement for endoscopy procedures from governments, which is one of the major factors responsible for physicians and patients opting for cheaper alternative options such as manual surgical or diagnostic procedures.

In 2021 High-level disinfectants (HLD) and test strips are expected to accounted the largest share of the endoscope reprocessing market, by product.

Based on product, the global endoscope reprocessing market is segmented into high-level disinfectants and test strips; detergents & wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). In 2021, the high-level disinfectants and test strips segment holds the largest share of the global endoscope reprocessing market. The large share of this segment is due to outbreak of infectious diseases to drive high-level disinfectants demand. Test strips are used to effectively measure the minimum recommended concentration of high-level disinfectants and provide fast disinfectant reaction time and a user-friendly color comparison chart to detect residual carbohydrate, protein, and hemoglobin to monitor the success of endoscope cleaning procedures

In 2021 Hospitals are expected to accounted the largest share of the endoscope reprocessing market, by end user.

Based on end users, the global endoscope reprocessing market is segmented into hospitals, ambulatory surgery centers and clinics, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2021, the hospitals' segment has the largest share due to large patient volume in hospitals related to endoscopic procedures leads to increase demand for endoscope reprocessing products in hospitals.

Endoscope Reprocessing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

In 2021 North America accounted the largest share of the endoscope reprocessing market.

Based on region, the endoscope reprocessing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America has the largest share of the endoscope reprocessing market. The largest share of North America can be attributed to factors such as the rising number of cancer cases, favorable reimbursement scenarios, and Increasing requirement for endoscopy to diagnose and treat target diseases.

Key Market Players

The major players operating in this market are Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), MEDALKAN (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market Size Available for Years

2017–2027

Base Year Considered

2021

Forecast Period

2022–2027

Forecast Units

Value (USD)

Segments Covered

Product, end user, and region

Geographies Covered

North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), APAC (Japan, China, India, and the RoAPAC), and Rest of the World (RoW) (Middle East & Africa and Latin America)

Companies Covered

Cantel Medical (US), Advanced Sterilization Products (ASP) (US), Olympus Corporation (Japan), Ecolab (US), STERIS (Ireland), Getinge AB (Sweden), Wassenburg Medical (Netherlands), CONMED Corporation (US), Belimed AG (Switzerland), Endo-Technik W. Griesat (Germany), Custom Ultrasonics (US), Steelco S.p.A. (Italy), BES Healthcare Ltd (UK), ARC Healthcare Solutions (Canada), Metrex Research, LLC. (Canada), Richard Wolf GmbH (Germany), MEDALKAN (Greece), Micro-Scientific, LLC (US), Borer Chemie AG (Switzerland), Tuttnauer (Netherlands), ATMS (Canada), Summit Imaging, Inc. (US), Medonica Co. LTD (South Korea), SHINVA MEDICAL INSTRUMENT CO. LTD (China), and Medical Devices Group Srl (Italy).

This research report categorizes the endoscope reprocessing market into the following segments and subsegments:

Endoscope Reprocessing Market by Product

  • High-Level Disinfectants and Test Strips
  • Detergents & Wipes
  • Automated Endoscope Reprocessors
    • AER, by Type
      • Single-basin AER
      • Double-basin AER
    • AER, by Portability
      • Standalone AER
      • Portable AER
  • Endoscope Drying, Storage, & Transport Systems
  • Endoscope Tracking Solutions
  • Other Products

Endoscope reprocessing Market by End User

  • Hospitals
  • Ambulatory Surgical Centers and Clinics
  • Other End Users

Endoscope reprocessing Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East & Africa

Recent Developments

  • In 2022, Getinge partnered with IFC to help increase access to medical equipment across Africa
  • In 2021, Getinge AB partnered with researchers from the School of Business, Economics, and Law at the University of Gothenburg, Sweden, on customer-centric innovation and sustainability. This will help the company gain access to the researchers’ socially relevant and applicable knowledge.
  • In 2021, Steelco S.p.A launched EW 1 S MAXI, which has been developed in conjunction with leading decontamination specialists and which incorporates all the latest technologies to increase safety, efficiency, and ease of use in the endoscope reprocessing practices
  • In 2020, ENDO-TECHNIK GmbH entered into a definitive agreement to ALBYN MEDICAL SL and Medi-Globe Group. The definitive agreement enables both companies to focus on their strategic objectives while continuing a lasting business relationship.
  • In 2020, Olympus Corporation launched OER-Elite.
  • In 2019, Fortive Corporation acquired Advanced Sterilization Products from Ethicon, Inc. (a subsidiary of Johnson & Johnsonthis acquisition enabled Fortive to portray an increased commitment to enhance the safe operations of hospitals and healthcare facilities worldwide.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

1 INTRODUCTION (Page No. - 33)
 
   1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKET SEGMENTATION
           1.3.2 GEOGRAPHIC SCOPE
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 38)
    2.1 RESEARCH DATA
           FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
           FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
           FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BELIMED AG (A METALL ZUG GROUP COMPANY).
           FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF ENDOSCOPE REPROCESSING PRODUCTS AND SERVICES
           FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
           FIGURE 8 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 STUDY ASSUMPTIONS
    2.5 RISK ASSESSMENT/FACTOR ANALYSIS
           TABLE 1 RISKS

3 EXECUTIVE SUMMARY (Page No. - 49)
   
FIGURE 10 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
    FIGURE 11 ENDOSCOPE REPROCESSING MARKET, BY END-USER, 2022 VS. 2027 (USD BILLION)
    FIGURE 12 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2022 VS. 2027 (USD BILLION)

4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 ENDOSCOPE REPROCESSING MARKET OVERVIEW
           FIGURE 13 RISING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT INCREASE IN ENDOSCOPIC PROCEDURES TO DRIVE MARKET GROWTH
    4.2 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SHARE, BY PRODUCT (2021)
           FIGURE 14 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS SEGMENT TO DOMINATE MARKET IN 2021
    4.3 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET
           FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 16 ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing requirement for endoscopy to diagnose and treat target diseases
                    5.2.1.2 High risk of endoscope-associated infections
                    5.2.1.3 Growing geriatric population and subsequent increase in endoscopic procedures
                    5.2.1.4 Increasing emphasis on improving reprocessing guidelines by healthcare authorities
                    5.2.1.5 Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy
                               TABLE 2 MAJOR DEVELOPMENTS
                    5.2.1.6 Increasing preference for minimally invasive surgeries
                    5.2.1.7 Rising focus of medical specialists and healthcare providers on shifting from manual to automated endoscopy reprocessing
           5.2.2 RESTRAINTS
                    5.2.2.1 Concerns related to reprocessed instrument safety
                    5.2.2.2 Adverse effects of chemical disinfectants
                    5.2.2.3 High overhead costs of endoscopy procedures with limited reimbursement in developing countries
                    5.2.2.4 High risk of COVID-19 transmission during endoscopic procedures
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing medical devices industry in emerging economies
                               FIGURE 17 MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION)
           5.2.4 CHALLENGES
                    5.2.4.1 Preference for single-use endoscopes
                    5.2.4.2 Increasing number of product failures and recalls
                    5.2.4.3 Shortage of trained professionals
                    5.2.4.4 Lack of awareness associated with reprocessing methods
                    5.2.4.5 Increasing FDA recommended measures to reduce infection transmission
    5.3 COVID-19 IMPACT ANALYSIS
           FIGURE 18 PERCENTAGE OF ENDOSCOPY PROCEDURES/PER WEEK BEFORE AND DURING COVID-19
    5.4 RANGES/ SCENARIOS
           5.4.1 ENDOSCOPE REPROCESSING MARKET
                     FIGURE 19 REALISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET
                     FIGURE 20 PESSIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET
                     FIGURE 21 OPTIMISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET
    5.5 REGULATORY ANALYSIS
           TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICE REPROCESSING
           5.5.1 NORTH AMERICA
                    5.5.1.1 US
                               FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR REPROCESSED MEDICAL DEVICES
                    5.5.1.2 Canada
                               TABLE 4 CANADA: REPROCESSING POLICIES OF SINGLE-USE MEDICAL DEVICES
           5.5.2 EUROPE
                    FIGURE 23 CE MARKING FOR REPROCESSED MEDICAL DEVICES
                    5.5.2.1 Germany
                    5.5.2.2 Rest of Europe
           5.5.3 ASIA PACIFIC
                    5.5.3.1 Japan
                    5.5.3.2 Australia
                    5.5.3.3 Rest of Asia Pacific
           5.5.4 LATIN AMERICA
           5.5.5 MIDDLE EAST & AFRICA
    5.6 PORTER’S FIVE FORCES ANALYSIS
           5.6.1 THREAT FROM NEW ENTRANTS
           5.6.2 BARGAINING POWER OF SUPPLIERS
           5.6.3 BARGAINING POWER OF BUYERS
           5.6.4 INTENSITY OF COMPETITIVE RIVALRY
           5.6.5 THREAT FROM SUBSTITUTES
    5.7 SUPPLY CHAIN ANALYSIS
           FIGURE 24 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES
    5.8 VALUE CHAIN ANALYSIS
           FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
    5.9 ECOSYSTEM ANALYSIS
           FIGURE 26 ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS
           5.9.1 ROLE IN ECOSYSTEM
                    FIGURE 27 KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET ECOSYSTEM
    5.10 TECHNOLOGY ANALYSIS
    5.11 KEY CONFERENCES & EVENTS IN 2022-2023
           TABLE 5 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
    5.12 PATENT ANALYSIS
           5.12.1 PATENT GRANTED TRENDS FOR ENDOSCOPE REPROCESSORS
                     FIGURE 28 PATENT GRANTED TRENDS OF AUTOMATED ENDOSCOPE REPROCESSORS, JANUARY 2011– APRIL 2022
                     FIGURE 29 PATENT GRANTED TRENDS OF HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011– FEBRUARY 2022
                     FIGURE 30 PATENT GRANTED TRENDS OF ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011– APRIL 2022
           5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS
                     FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AUTOMATED ENDOSCOPE REPROCESSORS PATENTS, JANUARY 2011—APRIL 2022
                     FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011—APRIL 2022
                     FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011— APRIL 2022
    5.13 TRADE ANALYSIS
           5.13.1 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021 (USD MILLION)
           5.13.2 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021 (USD MILLION)
           5.13.3 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021
           5.13.4 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021
    5.14 PRICING ANALYSIS
           TABLE 6 AVERAGE SELLING PRICES OF ENDOSCOPE REPROCESSING EQUIPMENT
           TABLE 7 AVERAGE SELLING PRICE FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY
           TABLE 8 COST OF CONSUMABLES INVOLVED IN REPROCESSING ENDOSCOPES WITH MANUAL CLEANING PLUS AER
           TABLE 9 TOTAL ESTIMATED COST FOR REPROCESSING ONE FLEXIBLE ENDOSCOPE
    5.15 KEY STAKEHOLDERS & BUYING CRITERIA
           5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS
                     TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS (%)
           5.15.2 BUYING CRITERIA
                     FIGURE 35 KEY BUYING CRITERIA FOR END USERS
                     TABLE 11 KEY BUYING CRITERIA FOR END USERS
    5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR ENDOSCOPE REPROCESSING MANUFACTURERS
                     FIGURE 36 REVENUE SHIFT FOR ENDOSCOPE REPROCESSING

6 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT (Page No. - 97)
    6.1 INTRODUCTION
           TABLE 12 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           TABLE 13 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
    6.2 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS
           6.2.1 OUTBREAK OF INFECTIOUS DISEASES TO DRIVE HIGH-LEVEL DISINFECTANTS AND TEST STRIPS DEMAND
                    TABLE 14 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 15 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2021–2027 (USD MILLION)
    6.3 DETERGENTS & WIPES
           6.3.1 INCREASING EMPHASIS ON PRE-CLEANING METHODS TO PROPEL SEGMENT GROWTH
                    TABLE 16 ENDOSCOPE REPROCESSING MARKET DETERGENTS & WIPES, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 17 ENDOSCOPE REPROCESSING MARKET FOR DETERGENTS & WIPES, BY REGION, 2021–2027 (USD MILLION)
    6.4 AUTOMATED ENDOSCOPE REPROCESSORS
           6.4.1 INCREASED EFFICIENCY OF AUTOMATED ENDOSCOPE REPROCESSORS OVER MANUAL CLEANING TO DRIVE MARKET GROWTH
                    TABLE 18 MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS
                    TABLE 19 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 20 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2021–2027 (USD MILLION)
           6.4.2 AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY
                    6.4.2.1 Introduction
                               TABLE 21 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 22 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2021–2027 (USD MILLION)
                    6.4.2.2 Standalone AER
                               TABLE 23 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2017–2020 (USD MILLION)
                               TABLE 24 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2021–2027 (USD MILLION)
                    6.4.2.3 Portable AER
                               TABLE 25 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2017–2020 (USD MILLION)
                               TABLE 26 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2021–2027 (USD MILLION)
           6.4.3 AUTOMATED ENDOSCOPE REPROCESSORS, BY TYPE
                    TABLE 27 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE, 2017–2020 (USD MILLION)
                    TABLE 28 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE, 2021–2027 (USD MILLION)
                    6.4.3.1 Single-basin AER
                               TABLE 29 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (SINGLE BASIN)
                    6.4.3.2 Double-basin AER
                               TABLE 30 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (DUAL BASIN)
    6.5 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS
           6.5.1 GUIDELINES FOR DRYING, STORAGE, AND TRANSPORTATION OF REPROCESSED ENDOSCOPES TO DRIVE MARKET GROWTH
                    TABLE 31 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS OFFERED
                    TABLE 32 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 33 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2021–2027 (USD MILLION)
    6.6 ENDOSCOPE TRACKING SYSTEMS
           6.6.1 RISING FOCUS ON REPROCESSING TO DRIVE SEGMENT GROWTH
                    TABLE 34 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 35 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2021–2027 (USD MILLION)
    6.7 OTHER PRODUCTS
           TABLE 36 OTHER PRODUCTS OFFERED BY MANUFACTURERS
           TABLE 37 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS, BY REGION, 2017–2020 (USD MILLION)
           TABLE 38 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS, BY REGION, 2021–2027 (USD MILLION)

7 ENDOSCOPE REPROCESSING MARKET, BY END USER (Page No. - 117)
    7.1 INTRODUCTION
           TABLE 39 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
           TABLE 40 ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
    7.2 HOSPITALS
           7.2.1 LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR ENDOSCOPE REPROCESSING PRODUCTS
                    TABLE 41 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 42 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION, 2021–2027 (USD MILLION)
    7.3 AMBULATORY SURGERY CENTERS AND CLINICS
           7.3.1 COST-EFFECTIVENESS OF AMBULATORY SURGERY CENTERS AND CLINICS TO DRIVE MARKET GROWTH
                    TABLE 43 NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY CENTERS IN US, 2013–2017
                    TABLE 44 TOTAL AMBULATORY SURGERY CENTER PROCEDURES IN US, 2015–2021
                    TABLE 45 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2017–2020 (USD MILLION)
                    TABLE 46 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2021–2027 (USD MILLION)
    7.4 OTHER END USERS
           TABLE 47 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY REGION, 2017–2020 (USD MILLION)
           TABLE 48 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS, BY REGION, 2021–2027 (USD MILLION)

8 ENDOSCOPE REPROCESSING MARKET, BY REGION (Page No. - 126)
    8.1 INTRODUCTION
           TABLE 49 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION)
           TABLE 50 ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021–2027 (USD MILLION)
    8.2 NORTH AMERICA
           FIGURE 37 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT
           TABLE 51 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 52 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021–2027 (USD MILLION)
           TABLE 53 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           TABLE 54 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
           TABLE 55 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
           TABLE 56 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
           TABLE 57 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
           TABLE 58 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.2.1 US
                    8.2.1.1 Favorable reimbursement scenario to propel market growth
                               TABLE 59 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2021
                               TABLE 60 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 61 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 62 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 63 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 64 US: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 65 US: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.2.2 CANADA
                    8.2.2.1 High prevalence of hospital-acquired infections to drive market growth
                               TABLE 66 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 67 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 68 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 69 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 70 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 71 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 72 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
    8.3 EUROPE
           TABLE 73 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 74 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021–2027 (USD MILLION)
           TABLE 75 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           TABLE 76 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
           TABLE 77 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
           TABLE 78 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
           TABLE 79 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
           TABLE 80 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.3.1 GERMANY
                    8.3.1.1 Increased surgical procedures to propel market growth
                               TABLE 81 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 82 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 83 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 84 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 85 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 86 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 87 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.3.2 UK
                    8.3.2.1 Increasing use of endoscopy procedures to drive market growth
                               FIGURE 38 MEAN PERCENTAGE CHANGE IN ENDOSCOPE PROCEDURE NUMBERS BETWEEN 2017 AND 2019
                               TABLE 88 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 89 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 90 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 91 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 92 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 93 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.3.3 FRANCE
                    8.3.3.1 Increasing prevalence of cancer to support market growth
                               TABLE 94 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 95 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 96 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 97 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 98 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 99 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 100 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.3.4 ITALY
                    8.3.4.1 Growing geriatric population to support market growth
                               TABLE 101 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 102 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 103 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 104 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 105 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 106 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 107 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.3.5 SPAIN
                    8.3.5.1 Developing healthcare infrastructure to support market growth
                               TABLE 108 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 109 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 110 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 111 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 112 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 113 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.3.6 REST OF EUROPE
                    TABLE 114 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                    TABLE 115 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                    TABLE 116 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                    TABLE 117 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                    TABLE 118 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                    TABLE 119 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
    8.4 ASIA PACIFIC
           FIGURE 39 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT
           TABLE 120 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION)
           TABLE 121 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021–2027 (USD MILLION)
           TABLE 122 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           TABLE 123 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
           TABLE 124 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
           TABLE 125 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
           TABLE 126 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
           TABLE 127 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.4.1 JAPAN
                    8.4.1.1 Increasing use of endoscopes to drive market growth
                               TABLE 128 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 129 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 130 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 131 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 132 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 133 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.4.2 CHINA
                    8.4.2.1 Rising prevalence of cancer to increase endoscopic procedures
                               TABLE 134 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 135 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 136 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 137 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 138 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 139 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 140 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.4.3 INDIA
                    8.4.3.1 Developing healthcare infrastructure to support market growth
                               TABLE 141 INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 142 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 143 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 144 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 145 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 146 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 147 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.4.4 REST OF ASIA PACIFIC
                    TABLE 148 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC COUNTRIES
                    TABLE 149 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                    TABLE 150 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                    TABLE 151 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                    TABLE 152 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                    TABLE 153 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                    TABLE 154 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
    8.5 REST OF THE WORLD
           TABLE 155 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION)
           TABLE 156 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021–2027 (USD MILLION)
           TABLE 157 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
           TABLE 158 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
           TABLE 159 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
           TABLE 160 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
           TABLE 161 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
           TABLE 162 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.5.1 LATIN AMERICA
                    8.5.1.1 Rising prevalence of infections due to endoscopy-related procedures to support market growth
                               TABLE 163 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
                               TABLE 164 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
                               TABLE 165 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES, 2018 VS. 2025
                               TABLE 166 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 167 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 168 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 169 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 170 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 171 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)
           8.5.2 MIDDLE EAST & AFRICA
                    8.5.2.1 Introduction of regulatory frameworks for medical equipment reprocessing to drive market growth
                               TABLE 172 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025
                               TABLE 173 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION)
                               TABLE 174 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION)
                               TABLE 175 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION)
                               TABLE 176 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION)
                               TABLE 177 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION)
                               TABLE 178 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION)

9 COMPETITIVE LANDSCAPE (Page No. - 195)
    9.1 OVERVIEW
    9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
           TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS
    9.3 REVENUE ANALYSIS
           FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET
    9.4 MARKET SHARE ANALYSIS
           FIGURE 41 ENDOSCOPE REPROCESSING MARKET SHARE ANALYSIS, 2020
           TABLE 180 ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION
    9.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
           9.5.1 STARS
           9.5.2 EMERGING LEADERS
           9.5.3 PERVASIVE PLAYERS
           9.5.4 PARTICIPANTS
                    FIGURE 42 VENDOR DIVE: ENDOSCOPE REPROCESSING MARKET
    9.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
           9.6.1 PROGRESSIVE COMPANIES
           9.6.2 STARTING BLOCKS
           9.6.3 RESPONSIVE COMPANIES
           9.6.4 DYNAMIC COMPANIES
                    FIGURE 43 ENDOSCOPE REPROCESSING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020
                    9.6.4.1 COMPETITIVE BENCHMARKING
                               TABLE 181 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUP/SMES
                               TABLE 182 ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [STARTUPS/SMES]
    9.7 COMPANY FOOTPRINT
           TABLE 183 COMPANY FOOTPRINT
           TABLE 184 COMPANY PRODUCT FOOTPRINT
           TABLE 185 COMPANY GEOGRAPHICAL FOOTPRINT
    9.8 COMPETITIVE SCENARIO AND TRENDS
           9.8.1 DEALS
                    TABLE 186 DEALS, JANUARY 2019- APRIL 2022
           9.8.2 PRODUCT LAUNCHES & APPROVALS
                    TABLE 187 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019- APRIL 2022
           9.8.3 EXPANSIONS
                    TABLE 188 EXPANSIONS, JANUARY 2019- APRIL 2022

10 COMPANY PROFILES (Page No. - 212)
     10.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 
             10.1.1 CANTEL MEDICAL
                        TABLE 189 CANTEL MEDICAL: BUSINESS OVERVIEW
                        FIGURE 44 CANTEL MEDICAL: COMPANY SNAPSHOT (2020)
             10.1.2 ADVANCED STERILIZATION PRODUCTS (FORTIVE)
                        TABLE 190 ADVANCED STERILIZATION PRODUCTS (FORTIVE): BUSINESS OVERVIEW
                        FIGURE 45 ADVANCED STERILIZATION PRODUCTS (FORTIVE): COMPANY SNAPSHOT (2020)
             10.1.3 OLYMPUS CORPORATION
                        TABLE 191 OLYMPUS CORPORATION: BUSINESS OVERVIEW
                        FIGURE 46 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)
             10.1.4 ECOLAB
                        TABLE 192 ECOLAB: BUSINESS OVERVIEW
                        FIGURE 47 ECOLAB: COMPANY SNAPSHOT (2021)
             10.1.5 STERIS
                        TABLE 193 STERIS: BUSINESS OVERVIEW
                        FIGURE 48 STERIS: COMPANY SNAPSHOT (2020)
             10.1.6 GETINGE AB
                        TABLE 194 GETINGE AB: BUSINESS OVERVIEW
                        FIGURE 49 GETINGE AB: COMPANY SNAPSHOT (2021)
             10.1.7 WASSENBURG MEDICAL (A MEMBER OF HOYA)
                        TABLE 195 WASSENBURG MEDICAL (A MEMBER OF HOYA): BUSINESS OVERVIEW
                        FIGURE 50 WASSENBURG MEDICAL (A MEMBER OF HOYA): COMPANY SNAPSHOT (2020)
             10.1.8 CONMED CORPORATION
                        TABLE 196 CONMED CORPORATION: BUSINESS OVERVIEW
                        FIGURE 51 CONMED CORPORATION: COMPANY SNAPSHOT (2021)
             10.1.9 BELIMED AG (A METALL ZUG GROUP COMPANY)
                        TABLE 197 BELIMED AG (METALL ZUG GROUP COMPANY): BUSINESS OVERVIEW
                        FIGURE 52 BELIMED AG (METALL ZUG GROUP COMPANY): COMPANY SNAPSHOT (2021)
             10.1.10 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL)
                        TABLE 198 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): BUSINESS OVERVIEW
                        FIGURE 53 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): COMPANY SNAPSHOT (2020)
             10.1.11 CUSTOM ULTRASONICS
                        TABLE 199 CUSTOM ULTRASONICS: BUSINESS OVERVIEW
             10.1.12 STEELCO S.P.A
                        TABLE 200 STEELCO S.P.A: BUSINESS OVERVIEW
             10.1.13 BES HEALTHCARE (A DIVISION OF BES REHAB LTD)
                        TABLE 201 BES HEALTHCARE: BUSINESS OVERVIEW
             10.1.14 ARC HEALTHCARE SOLUTIONS
                        TABLE 202 ARC HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW
             10.1.15 METREX RESEARCH, LLC
                        TABLE 203 METREX RESEARCH. LLC: BUSINESS OVERVIEW
     10.2 OTHER PLAYERS
             10.2.1 RICHARD WOLF GMBH
                        TABLE 204 RICHARD WOLF GMBH: BUSINESS OVERVIEW
             10.2.2 MEDALKAN
                        TABLE 205 MEDALKAN: BUSINESS OVERVIEW
             10.2.3 MICRO-SCIENTIFIC, LLC
                        TABLE 206 MICRO-SCIENTIFIC, LLC: BUSINESS OVERVIEW
             10.2.4 BORER CHEMIE AG
                        TABLE 207 BORER CHEMIE AG: BUSINESS OVERVIEW
             10.2.5 MEDONICA CO. LTD
                        TABLE 208 MEDONICA CO. LTD: BUSINESS OVERVIEW
             10.2.6 TUTTNAUER
                        TABLE 209 TUTTNAUER: BUSINESS OVERVIEW
             10.2.7 ATMS
                        TABLE 210 ATMS: BUSINESS OVERVIEW
             10.2.8 SUMMIT IMAGING, INC.
                        TABLE 211 SUMMIT IMAGING, INC.: BUSINESS OVERVIEW
             10.2.9 SHINVA MEDICAL INSTRUMENT CO., LTD
                        TABLE 212 SHINVA MEDICAL INSTRUMENT CO., LTD: BUSINESS OVERVIEW
             10.2.10 MEDICAL DEVICES GROUP SRL
                        TABLE 213 MEDICAL DEVICES GROUP SRL: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 

11 APPENDIX (Page No. - 260)
     11.1 DISCUSSION GUIDE
     11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.3 AVAILABLE CUSTOMIZATIONS
     11.4 RELATED REPORTS
     11.5 AUTHOR DETAILS

The study involved four major activities to estimate the current size of the endoscope reprocessing market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.

Primary Research

Several stakeholders such as endoscope reprocessing manufacturers, vendors, distributors, and physicians from hospitals and clinics were consulted for this report. The demand side of this market is characterized by increasing preference for endoscopic procedures, high risk of endoscope-associated infections, growing geriatric population and the subsequent increase of endoscopic procedures, and increasing emphasis on improving reprocessing guidelines by healthcare facilities. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Endoscope Reprocessing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the endoscope reprocessing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the endoscope reprocessing industry.

Report Objectives

  • To define, describe, and forecast the endoscope reprocessing market based on product, end user, and region.
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, and opportunities, COVID-19 Impact Analysis)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscope reprocessing market
  • To analyse market opportunities for stakeholders and provide details of the competitive landscape for key players.
  • To forecast the size of the market segments in four geographical regions, namely, North America, Europe, the Asia Pacific, and Rest of the World.
  • To profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies.
  • To track and analyse competitive developments such as product launches and approvals, deals and expansions in the endoscope reprocessing market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis:

  • Further breakdown of the endoscope reprocessing market into specific countries/regions in the Rest of Europe, Rest of Asia Pacific, Middle East & African, and Latin American countries

Company Information:

  • Detailed analysis and profiling of additional market players (up to 5) inclusive of:
  • Business Overview
  • Financial Information
  • Product Portfolio
  • Developments (last three years)
Report Code
MD 5654
Published ON
May, 2022
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Endoscope Reprocessing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved